COMMITMENTS AND CONTINGENCIES - Legal Proceedings and License Agreement (Details) - License Agreement - Iogen, LLC.	12 Months Ended
Jan. 31, 2017
License Agreement
Non Royalty license fee equal to a certain percentage of net profit associated with OTC product	30.00%
Non Royalty license fee equal to a certain percentage of net royalties received from any sub-licensee	30.00%
Prescription Iodine Tablet
License Agreement
Royalty fee percentage based on net sales over a specific time period of commercialization	3.00%
Royalty fee percentage based on net sales after a specific period of time	2.00%
Time period for determining initial royalty fee as a percent of net sales	24 months
Other Products
License Agreement
Royalty fee percentage based on net sales over a specific time period of commercialization	3.00%
Royalty fee percentage based on net sales from initial period until expiration of applicable patents	2.00%
Royalty fee percentage based on net sales after a specific period of time	1.00%
Time period for determining initial royalty fee as a percent of net sales	12 months

- Definition

Represents the non-royalty license fees equal to a certain percentage of net profit associated with direct commercialization of an OTC product.

+ References

No definition available.

+ Details

Name:	bpmx_NonRoyaltyLicenseFeeEqualToCertainPercentageOfNetProfit
Namespace Prefix:	bpmx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the non-royalty license fee equal to a certain percentage of net royalties received from any sub-licensee.

+ References

No definition available.

+ Details

Name:	bpmx_NonRoyaltyLicenseFeeEqualToCertainPercentageOfNetRoyaltiesReceivedFromSubLicensee
Namespace Prefix:	bpmx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Period of time for determining initial royalty fee as a percent of net sales.

+ References

No definition available.

+ Details

Name:	bpmx_RoyaltyFeeInitialPeriodOfTime
Namespace Prefix:	bpmx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the royalty fee percentage based on net sales over a specific time period of commercialization.

+ References

No definition available.

+ Details

Name:	bpmx_RoyaltyFeePercentOfNetSales
Namespace Prefix:	bpmx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the royalty fee percentage based on net sales from initial period until expiration of applicable patents.

+ References

No definition available.

+ Details

Name:	bpmx_RoyaltyFeePercentOfNetSalesUntilExpiration
Namespace Prefix:	bpmx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the royalty fee percentage based on net sales after a specific period of time.

+ References

No definition available.

+ Details

Name:	bpmx_RoyaltyFeePercentageOfNetSalesAfterSpecificTimePeriod
Namespace Prefix:	bpmx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=bpmx_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CounterpartyNameAxis=bpmx_IogenLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=bpmx_PrescriptionIodineTabletMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=bpmx_OtherProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: